Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Irritable Bowel Syndrome

  Free Subscription


1 Benef Microbes
1 BMJ Open Gastroenterol
1 Brain Sci
1 Cureus
1 Front Immunol
1 Gastroenterol Hepatol
1 Gut
1 Gut Liver
1 Int J Gen Med
1 Int J Mol Sci
1 Intern Emerg Med
1 J Assoc Physicians India
1 J Biomed Sci
2 J Ethnopharmacol
1 J Gastroenterol Hepatol
1 J Psychosom Res
1 Microorganisms
1 MMW Fortschr Med
3 Neurogastroenterol Motil
1 Nutrients
1 Surg Clin North Am
2 World J Gastroenterol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Benef Microbes

  1. TORRES-MARAVILLA E, Carvalho FA, Holowacz S, Delannoy J, et al
    Screening of probiotic strains to improve visceral hypersensitivity in irritable bowel syndrome by using in vitro and in vivo approaches.
    Benef Microbes. 2024 Apr 30:1-18. doi: 10.1163/18762891-bja00006.
    PubMed         Abstract available


  2. SAUL H, Cassidy S, Swaithes L, Ford A, et al
    Irritable bowel syndrome: low dose antidepressant improves symptoms.
    BMJ. 2024;385:q871.
    PubMed         Abstract available

    BMJ Open Gastroenterol

  3. NYBOE ANDERSEN N, Wildt S, Iversen AT, Poulsen G, et al
    Risk of cancer in patients with bile acid diarrhoea: a Danish nationwide matched cohort study.
    BMJ Open Gastroenterol. 2024;11:e001340.
    PubMed         Abstract available

    Brain Sci

  4. SAROJ A, Tripathi A, Rungta S, Kar SK, et al
    Psychiatric Co-Morbidities and Profile of Patients with Irritable Bowel Syndrome in Northern India.
    Brain Sci. 2024;14:393.
    PubMed         Abstract available


  5. MOHAMMED C, Fuego JP, Garcia KV, Jamil H, et al
    A Mini Literature Review of Probiotics: Transforming Gastrointestinal Health Through Evidence-Based Insights.
    Cureus. 2024;16:e57055.
    PubMed         Abstract available

    Front Immunol

  6. ZHAO L, Zhang T, Zhang K
    Pharmacological effects of ginseng and ginsenosides on intestinal inflammation and the immune system.
    Front Immunol. 2024;15:1353614.
    PubMed         Abstract available

    Gastroenterol Hepatol

  7. SERRA J, Aguilar A, Barba E, de Los Rios CC, et al
    Gastroenterol Hepatol. 2024 Apr 25:S0210-5705(24)00145.
    PubMed         Abstract available


  8. FORD AC, Staudacher HM, Talley NJ
    Postprandial symptoms in disorders of gut-brain interaction and their potential as a treatment target.
    Gut. 2024 May 2:gutjnl-2023-331833. doi: 10.1136/gutjnl-2023-331833.
    PubMed         Abstract available

    Gut Liver

  9. RAY G, Ghoshal UC
    Epidemiology of Disorders of the Gut-Brain Interaction: An Appraisal of the Rome IV Criteria and Beyond.
    Gut Liver. 2024 Apr 29. doi: 10.5009/gnl230396.
    PubMed         Abstract available

    Int J Gen Med

  10. CHOI Y, Ha NY, Kim AR, Jeong H, et al
    Modified Gwakjeongtang for Diarrhea-Predominant Irritable Bowel Syndrome: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Trial.
    Int J Gen Med. 2024;17:1545-1556.
    PubMed         Abstract available

    Int J Mol Sci

  11. CHIMIENTI G, Russo F, Bianco A, Maqoud F, et al
    Effect of a 12-Week Walking Program Monitored by Global Physical Capacity Score (GPCS) on Circulating Cell-Free mtDNA and DNase Activity in Patients with Irritable Bowel Syndrome.
    Int J Mol Sci. 2024;25:4293.
    PubMed         Abstract available

    Intern Emerg Med

  12. CARABOTTI M, Marasco G, Sbarigia C, Cuomo R, et al
    Site and duration of abdominal pain discriminate symptomatic uncomplicated diverticular disease from previous diverticulitis patients.
    Intern Emerg Med. 2024 Apr 27. doi: 10.1007/s11739-024-03588.
    PubMed         Abstract available

    J Assoc Physicians India

  13. ABRAHAM P, Pratap N
    Dysbiosis in Irritable Bowel Syndrome.
    J Assoc Physicians India. 2023;71:75-81.
    PubMed         Abstract available

    J Biomed Sci

  14. TIKHOMIROVA A, McNabb ER, Petterlin L, Bellamy GL, et al
    Campylobacter jejuni virulence factors: update on emerging issues and trends.
    J Biomed Sci. 2024;31:45.
    PubMed         Abstract available

    J Ethnopharmacol

  15. JIA F, Du L, He J, Zhang Z, et al
    Tong-Xie-Yao-Fang strengthens intestinal feedback control of bile acid synthesis to ameliorate irritable bowel syndrome by enhancing bile salt hydrolase-expressing microbiota.
    J Ethnopharmacol. 2024 Apr 25:118256. doi: 10.1016/j.jep.2024.118256.
    PubMed         Abstract available

  16. ZHANG S, Tian D, Xia Z, Yang F, et al
    Chang-Kang-Fang alleviates diarrhea predominant irritable bowel syndrome (IBS-D) through inhibiting TLR4/NF-kappaB/NLRP3 pathway.
    J Ethnopharmacol. 2024;330:118236.
    PubMed         Abstract available

    J Gastroenterol Hepatol

  17. NG QX, Yaow CYL, Moo JR, Koo SWK, et al
    A systematic review of the association between environmental risk factors and the development of irritable bowel syndrome.
    J Gastroenterol Hepatol. 2024 May 3. doi: 10.1111/jgh.16587.
    PubMed         Abstract available

    J Psychosom Res

  18. VAN DER MEULEN ML, Bos M, Bakker SJL, Gans ROB, et al
    Validity and diagnostic overlap of functional somatic syndrome diagnoses.
    J Psychosom Res. 2024;181:111673.
    PubMed         Abstract available


  19. MAHDI T, Desmons A, Krasniqi P, Lacorte JM, et al
    Effect of Stool Sampling on a Routine Clinical Method for the Quantification of Six Short Chain Fatty Acids in Stool Using Gas Chromatography-Mass Spectrometry.
    Microorganisms. 2024;12:828.
    PubMed         Abstract available

    MMW Fortschr Med

  20. ZINK N
    [Not Available].
    MMW Fortschr Med. 2024;166:10.

    Neurogastroenterol Motil

  21. PATHIPATI MP, Scott LL, Griser AC, Staller K, et al
    Real-world outcomes for a digital prescription mobile application for adults with irritable bowel syndrome.
    Neurogastroenterol Motil. 2024 Apr 30:e14811. doi: 10.1111/nmo.14811.
    PubMed         Abstract available

  22. HILLESTAD EMR, Steinsvik EK, Teige ES, Rasmussen SH, et al
    Nutritional safety and status following a 12-week strict low FODMAP diet in patients with irritable bowel syndrome.
    Neurogastroenterol Motil. 2024 Apr 30:e14814. doi: 10.1111/nmo.14814.
    PubMed         Abstract available

  23. NOJKOV B, Burnett C, Watts L, Yin J, et al
    The impact of transcutaneous electrical acustimulation (TEA) on rectal distension-induced pain in patients with irritable bowel syndrome (IBS)-A study to determine the optimal TEA delivery modalities and effects on rectal sensation and autonomic funct
    Neurogastroenterol Motil. 2024 Apr 26:e14799. doi: 10.1111/nmo.14799.
    PubMed         Abstract available


  24. WADE U, Pascual-Figal DA, Rabbani F, Ernst M, et al
    The Possible Synergistic Pharmacological Effect of an Oral Berberine (BBR) and Curcumin (CUR) Complementary Therapy Alleviates Symptoms of Irritable Bowel Syndrome (IBS): Results from a Real-Life, Routine Clinical Practice Settings-Based Study.
    Nutrients. 2024;16:1204.
    PubMed         Abstract available

    Surg Clin North Am

  25. O'DONNELL MT, Haviland SM
    Functional Constipation and Obstructed Defecation.
    Surg Clin North Am. 2024;104:565-578.
    PubMed         Abstract available

    World J Gastroenterol

  26. DAI C, Huang YH, Jiang M
    Fecal microbiota transplantation for irritable bowel syndrome: Current evidence and perspectives.
    World J Gastroenterol. 2024;30:2179-2183.
    PubMed         Abstract available

  27. VALIBOUZE C, Dubuquoy C, Chavatte P, Genin M, et al
    Chitin-glucan improves important pathophysiological features of irritable bowel syndrome.
    World J Gastroenterol. 2024;30:2258-2271.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Irritable Bowel Syndrome is free of charge.